Richter CEO: profitability improved in all business lines, high single-digit revenue growth possible
Cost levels and profitability have improved in all business lines, and this year pharmaceutical production revenues may achieve high single-digit growth adjusted for exchange rates – said Gábor Orbán, CEO of Gedeon Richter Plc., in his online briefing following the flash report on Friday.
He pointed out that they do not provide stable performance on a quarterly basis, but rather think “on an annual or multi-year horizon“. The trade war left its mark on 2025, this year will no longer be about that, he said in response to MTI’s question.
He added: gynecology is one of their largest and fastest-growing business lines. Thanks to the innovative portfolio, they achieved the revenue growth in pharmaceutical production that was in line with their goals, which increased by 8.3 percent to nearly 2.31 billion euros last year, adjusted for exchange rates.
Related news
Richter acquires Celmatix research portfolio
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >World Rare Disease Day: advances in clinical trials and expansion of genetic diagnostics are essential for the development of precision medicine
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >The future doesn’t wait: Bosch and Richter are looking for a new generation of innovators
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Related news
SPAR renovated three of its stores with an investment of 880 million forints
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >The government is helping dairy farmers with another 7 billion forints
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Vál-Völgye Bakery won ten awards at the 22nd International Bread Competition
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >


